Banner Ads

Alembic Pharma rating – Hold: India sales bright spot of Q3FY21 https://ift.tt/eA8V8J

January 25, 2021 at 07:45AM
Execution key for India and US sales; FY21-22e EPS up 3%; valuations factor in prospects; ‘Hold’ retained

from The Financial Express

Post a Comment

0 Comments